Conversation with The Cancer Letter Miller: “Doctors and patients have confidence in knowing that a test has gone through FDA” February 02, 2018Vol.44 No.05By Paul Goldberg
Conversation with The Cancer LetterFree Gary Reedy describes plan for turning around the American Cancer Society January 26, 2018Vol.44 No.04By Paul Goldberg
Conversation with The Cancer LetterFree Hostin: Roche-Syapse programs will increase amount and depth of risk-benefit info in precision oncology January 12, 2018Vol.44 No.02By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Syapse: Roche collaboration enables us to experiment with new technology January 12, 2018Vol.44 No.02By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Lefkofsky: CancerLinQ has value in ushering in an era of precision medicine December 21, 2017Vol.44 No.01By Paul Goldberg
Conversation with The Cancer LetterFree Hudis: ASCO needed collaborators to help CancerLinQ deliver faster on its mission December 21, 2017Vol.44 No.01By Paul Goldberg
Conversation with The Cancer Letter Caligiuri: It was time for me to hit the refresh button on my career November 28, 2017Vol.43 No.44By Matthew Bin Han Ong and Paul Goldberg
Conversation with The Cancer Letter Trump’s plans for Inova reach across the Washington Beltway, through Virginia—and beyond November 10, 2017Vol.43 No.42By Paul Goldberg
Conversation with The Cancer Letter Peter Pisters reflects on the upcoming challenge: leading MD Anderson November 03, 2017Vol.43 No.41By Paul Goldberg
Conversation with The Cancer Letter Storniolo: The Komen Tissue Bank fills the gap in understanding of “normal” October 27, 2017Vol.43 No.40By Matthew Bin Han Ong
